The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Grushina T.I.

Moscow Research and Practical Center for Medical Rehabilitation, Restorative and Sports Medicine, Moscow Healthcare Department, Moscow, Russia

Zikiryakhodzhaev A.D.

P.A. Herzen Moscow Oncology Research Institute, Ministry of Health of Russia, Moscow

Starkova M.V.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia, Moscow, Russia

Experience in using the International Classification of Functioning, Disability and Health in patients with breast cancer after surgical treatment

Authors:

Grushina T.I., Zikiryakhodzhaev A.D., Starkova M.V.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2018;7(5): 21‑32

Read: 2363 times


To cite this article:

Grushina TI, Zikiryakhodzhaev AD, Starkova MV. Experience in using the International Classification of Functioning, Disability and Health in patients with breast cancer after surgical treatment. P.A. Herzen Journal of Oncology. 2018;7(5):21‑32. (In Russ.)
https://doi.org/10.17116/onkolog2018705121

References:

  1. International Classification of Functioning, Disability and Health: ICF, Short Version. Geneva, Switzerland: WHO; 2001.
  2. Shoshmin AV, Ponomarenko GN, Besstrashnova YaK, Cherkashina IV. The application of the International Classification of functioning, disability and health for the evaluation of the effectiveness of rehabilitation: methodology, practical experience, results. Voprosy kurortologii, fizioterapii i lechebnoy fizicheskoy kultury. 2016;93(6):12-20. (In Russ.) https://doi.org/10.17116/kurort2016612-20
  3. Schumacher A, Sikov WM, Quesenberry MI, Safran H, Khurshid H, Mitchell KM, Olszewski AJ. Informed consent in oncology clinical trials: A Brown University Oncology Research Group prospective cross-sectional pilot study. PLoS One. 2017;12(2):e0172957. https://doi.org/10.1371/journal.pone.0172957
  4. Fayed N, Cieza A, Bickenbach JE. Linking health and health-related information to the ICF: a systematic review of the literature from 2001 to 2008. Disabil Rehabil. 2011;33(21-22):1941-1951. https://doi.org/10.3109/09638288.2011.553704
  5. Glaessel A, Kirchberger I, Stucki G, Cieza A. Does the comprehensive international classification of functioning, disability and health (ICF) Core Set for Breast Cancer capture the problems in functioning treated by physiotherapists in women with breast cancer? Physiotherapy. 2011;97(1):33-46. https://doi.org/10.1016/j.physio.2010.08.010
  6. Kisser U, Adderson-Kisser C, Coenen M, Stier-Jarmer M, Becker S, Sabariego C, Harréus U. The development of an ICF-based clinical guideline and screening tool for the standardized assessment and evaluation of functioning after head and neck cancer treatment. Eur Arch Otorinolaryngol. 2016;274(2):1035-1043. https://doi.org/10.1007/s00405-016-4317-6
  7. Yang EJ, Shin EK, Shin HI, Lim JY. Psychometric properties of scale constructed from the International Classification of Functioning, Disability and Health (ICF) core set for breast cancer based on Rasch analysis. Support Care Cancer. 2014;22(10):2839-2849. https://doi.org/10.1007/s00520-014-2277-1
  8. Cooney M, Galvin R, Connolly E, Stokes E. The International Classification of Functioning (ICF) core set for breast cancer from the perspective of women with the condition. Disabil Rehabil. 2013;35(9):740-748. https://doi.org/10.3109/09638288.2012.707742
  9. Giardini A, Pisoni C, Giorgi I, Borelli V, Scoccia E, Majani G. ICF, quality of life, and depression in breast cancer: perceived disability in disease-free women 6 months after mastectomy. Support Care Cancer. 2013;21(9):2453-2460. https://doi.org/10.1007/s00520-013-1794-7
  10. Bornbaum CC, Doyle PC, Skarakis-Doyle E, Theurer JA. A critical exploration of the International Classification of Functioning, Disability, and Health (ICF) framework from the perspective of oncology: recommendations for revision. J Multidiscip Healthc. 2013;6:75-86. https://doi.org/10.2147/JMDH.S40020
  11. Brach M, Cieza A, Stucki G, Füssl M, Cole A, Ellerin B, et al. ICF Core Sets for breast cancer. J Rehabil Med. 2004;36:121-127. https://doi.org/10.1080/16501960410016811
  12. Donker M, van Tienhoven G, Straver M, Meijnen P, van de Velde C, Mansel R, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): A randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303-1310. https://doi.org/10.1016/s1470-2045(14)70460-7
  13. Fisher B, Jeong J, Anderson S, Bryant J, Fisher E, Wolmark N, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347(8):567-575. https://doi.org/10.1056/nejmoa020128
  14. Galimberti V, Cole B, Zurrida S, Viale G, Luini A, Veronesi P. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14(4):297-305. https://doi.org/10.1016/s1470-2045(13)70035-4
  15. Giuliano A, Ballman K, McCall L, Beitsch P, Whitworth P, Blumencranz P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases. Ann Surg. 2016;264(3):413-420. https://doi.org/10.1097/sla.0000000000001863
  16. Krag D, Anderson S, Julian T, Brown A, Harlow S, Costantino J, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927-933. https://doi.org/10.1016/s1470-2045(10)70207-2
  17. Sávolt Á, Polgár C, Musonda P, Mátrai Z, Rényi-Vámos F, Tóth L. Does the result of completion axillary lymph node dissection influence the recommendation for adjuvant treatment in sentinel lymph node-positive patients? Clin Breast Cancer. 2013;13(5):364-370. https://doi.org/10.1016/j.clbc.2013.04.004
  18. Solá M, Alberro J, Fraile M, Santesteban P, Ramos M, Fabregas R, et al. Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM048/13/2000. Ann Surg Oncol. 2012;20(1):120-127. https://doi.org/10.1245/s10434-012-2569-y
  19. Grushina TI, Tkachenko GA. Psychological distress in breast cancer patients after different types of treatment. Opukholi zhenskoy reproduktivnoy sistemy. 2016;12(1):56-62. (In Russ.) https://doi.org/10.17650/1994-4098-2016-12-1-56-62
  20. Grushina TI, Tkachenko GA. Rehabilitation of breast cancer patients: fisiotherapy, farmacotherapy and psychocorrection (Reabilitatsiya pri rake molochnoi zhelezy: fizioterapiya, farmakoterapiya i psikhokorrektsiya). Moscow: Avtorskaya akademiya; 2017. (In Russ.)

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.